SEED Innovations Ltd (AIM:SEED) investee company Little Green Pharma Ltd (ASX:LGP) (LGP) has shipped its first branded cannabis flower medicines to Australia, from its facility in Denmark.
LGP, which is 3.1% owned by SEED, has shipped 50 kilograms of its ‘Billy Buttons’ cannabis flower medicine - with 16% tetrahydrocannabinol (THC) content - which is to be sold in 15 gram packs. Two further Australian imports of cannabis flower medicines are scheduled from the Danish facility before the end of October, LGP noted.
Fleta Solomon, LGP managing director, described it as a landmark achievement.
“To be able to meet all the regulatory requirements to supply and import product within this timeframe is a significant achievement and consistent with our reputation as a leading global medicinal cannabis business,” Solomon said.
“Flower medicines are becoming increasingly popular with Australian doctors in prescribing to patients for quick onset of effects, mainly for breakthrough pain or to assist with sleep, and with access to this Denmark-grown product we are able to provide a new supply chain of high-quality, medicinal cannabis flower in an under-supplied market.”
LGP also noted new management appointments with Morten Snede joining as chief financial officer and Tony Roberts appointed as general manager for the EU territory.